Your browser doesn't support javascript.
loading
Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer.
Chüeh, Anderly C; Liew, Mun-Sem; Russell, Prudence A; Walkiewicz, Marzena; Jayachandran, Aparna; Starmans, Maud H W; Boutros, Paul C; Wright, Gavin; Barnett, Stephen A; Mariadason, John M; John, Thomas.
Afiliación
  • Chüeh AC; Ludwig Institute of Cancer Research, Melbourne-Austin Branch, Victoria, Australia.
  • Liew MS; Department of Medicine, Austin Health, University of Melbourne, Victoria, Australia.
  • Russell PA; Ludwig Institute of Cancer Research, Melbourne-Austin Branch, Victoria, Australia.
  • Walkiewicz M; Department of Medicine, Austin Health, University of Melbourne, Victoria, Australia.
  • Jayachandran A; Olivia Newton-John Cancer Research Institute, Victoria, Australia.
  • Starmans MHW; Department of Anatomical Pathology, St Vincent's Hospital, Victoria, Australia.
  • Boutros PC; Ludwig Institute of Cancer Research, Melbourne-Austin Branch, Victoria, Australia.
  • Wright G; Olivia Newton-John Cancer Research Institute, Victoria, Australia.
  • Barnett SA; Ludwig Institute of Cancer Research, Melbourne-Austin Branch, Victoria, Australia.
  • Mariadason JM; Olivia Newton-John Cancer Research Institute, Victoria, Australia.
  • John T; School of Cancer Medicine, La Trobe University, Victoria, Australia.
Oncotarget ; 8(43): 74036-74048, 2017 Sep 26.
Article en En | MEDLINE | ID: mdl-29088766

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos